Evaluation/Desired Outcomes

• Decreased pain and swelling with decreased rate of joint destruction in patients with rheumatoid arthritis

• Decreased signs and symptoms, slowed progression of joint destruction, and improved physical function in patients with psoriatic arthritis

• Reduced signs and symptoms of ankylosing spondylitis

• Decreased signs and symptoms and maintenance of remission in patients with Crohn's disease

adalimumab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.